LawrenceWMyersMD

Neurology • Los Angeles, CA

Physician

Join to view full profile

Are you Dr. Myers?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 20 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
300 Medical Plaza
B200
Los Angeles, CA 90095
Phone+1 310-794-1195

Fax+1 310-301-8751
Is this information wrong?

Summary

Dr. Lawrence Myers, MD is a board certified neurologist in Los Angeles, California. He is currently licensed to practice medicine in California.

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 1969 - 1971
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1967 - 1969
University of Texas Medical Branch HospitalsInternship, Transitional Year, 1964 - 1965
SUNY Upstate Medical UniversityClass of 1964

Certifications & Licensure

CA State Medical License Active through 2014
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Whos Who in Medicine and Healthcare Marquis Whos Who

Publications & Presentations

PubMed

156 citations
Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer a...
Corey C. Ford, Andrew D. Goodman, Kenneth P. Johnson, Norman J Kachuck, J. W. Lindsey, Robert P. Lisak, Christopher Luzzio, Lawrence W. Myers, Hillel Panitch, Jana Liz...> ;Multiple Sclerosis. 2010 Jan 27
37 citations
The Association of HLA Antigens A3, B7, and DW2 with 330 Multiple Sclerosis Patients in the United States
Gerhard Opelz, Paul I. Terasaki, Lawrence W. Myers, George W. Ellison, G. Ebers, J. B. Zabriskie, Howard L. Weiner, H. Kempe, W. Sibley> ;Tissue Antigens. 2008 Dec 11
1 citations
Cerebrospinal fluid immunoglobulin G promotes oligodendrocyte progenitor cell migration
Seema K. Tiwari-Woodruff, Lawrence W. Myers, Jeff M. Bronstein> ;Journal of Neuroscience Research. 2004 Aug 1
46 citations
Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial
Kenneth P. Johnson, Benjamin Rix Brooks, Corey C. Ford, Andrew D. Goodman, R. P. Lisak, Lawrence W. Myers, A. A. Pruitt, M. A. Rizzo, John W. Rose, Leslie P. Weiner, J...> ;Multiple Sclerosis. 2003 Dec 1
11 citations
Predictors of short-term disease activity following a first clinical demyelinating event: Analysis of the CHAMPS placebo group
Paul O'Connor, P. Fleming, Trevor A. Gray, Lawrence Jacobs, C. Miller, Frederick Munschauer, R. P. Kinkel, D. Bolibrush, Jeffrey A. Cohen, Mark S. Freedman, U. Webb, H...> ;Multiple Sclerosis. 2002 Jan 1
32 citations
Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. 1998 [cl...
Kenneth P. Johnson, Benjamin Rix Brooks, J. A. Cohen, Corey C. Ford, Jonathan Goldstein, Robert P. Lisak, Lawrence W. Myers, Hillel Panitch, John W. Rose, Randolph B. ...> ;Neurology. 2001 Dec 1
88 citations
Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlle...
K P Johnson, B R Brooks, J A Cohen, C C Ford, J Goldstein, R P Lisak, L W Myers, H S Panitch, J W Rose, R B Schiffer, T Vollmer, L P Weiner, J S Wolinsky> ;Neurology. 2001 Dec 1
22 citations
Factors related to agreement between self-reported and conventional Expanded Disability Status Scale (EDSS) scores
Eric M. Cheng, Ron D. Hays, Lawrence W. Myers, George W. Ellison, M. Beckstrand, Barbara G. Vickrey> ;Multiple Sclerosis. 2001 Dec 1
19 citations
T-cell responses to oligodendrocyte-specific protein in multiple sclerosis.
T. Vu, Lawrence W. Myers, George W. Ellison, F. Mendoza, Jeff M. Bronstein> ;Journal of Neuroscience Research. 2001 Nov 1
44 citations
Mobility impairments and use of preventive services in women with multiple sclerosis: observational study
Eric M. Cheng, Lawrence W. Myers, Sheldon M. Wolf, Deborah Shatin, Xinping Cui, George T. H. Ellison, Thomas Belin, Barbara G. Vickrey> ;BMJ. 2001 Oct 27
8 citations
Immunologic therapy for secondary and primary progressive multiple sclerosis.
Lawrence W. Myers> ;Current Neurology and Neuroscience Reports. 2001 May 1
46 citations
Management of multiple sclerosis across managed care and fee-for-service systems
Barbara G. Vickrey, D. Shatin, Sheldon M. Wolf, Lawrence W. Myers, Thomas R. Belin, Rebecca A. Hanson, Martin F. Shapiro, M. Beckstrand, Z.V. Edmonds, S. Delrahim, Geo...> ;Neurology. 2000 Nov 14
169 citations
Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years. Copolymer 1 Multiple Sclerosis Study Group.
Kenneth P. Johnson, Benjamin Rix Brooks, Corey C. Ford, Andrew D. Goodman, J. Guarnaccia, Robert P. Lisak, Lawrence W. Myers, Hillel Panitch, A. Pruitt, John W. Rose, ...> ;Multiple Sclerosis. 2000 Aug 1
33 citations
General neurologist and subspecialist care for multiple sclerosis: patients' perceptions.
Barbara G. Vickrey, Z.V. Edmonds, D. Shatin, Martin F. Shapiro, S. Delrahim, Thomas R. Belin, George W. Ellison, Lawrence W. Myers> ;Neurology. 1999 Oct 1
51 citations
A humoral response to oligodendrocyte-specific protein in MS: a potential molecular mimic.
Jeff M. Bronstein, Roger L. Lallone, Robert S. Seitz, George W. Ellison, Lawrence W. Myers> ;Neurology. 1999 Jul 1
11 citations
Pentoxifylline is not a promising treatment for multiple sclerosis in progression phase
Lawrence W. Myers, GeorgeW. Ellison, Jean E. Merrill, A. El Hajjar, B. St. Pierre, M. Hijazin, B. D. Leake, J. R. Bentson, Marc R. Nuwer, Wallace W. Tourtellotte, Patr...> ;Neurology. 1998 Nov 1
352 citations
Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability
Kenneth P. Johnson, Benjamin Rix Brooks, Jeffrey A. Cohen, Corey C. Ford, Jonathan Goldstein, R. P. Lisak, Lawrence W. Myers, Hillel Panitch, J. W. Rose, R. B. Schiffe...> ;Neurology. 1998 Mar 1
118 citations
Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis
Barbara G. Vickrey, Ron D. Hays, Barbara Genovese, Lawrence W. Myers, George W. Ellison> ;Journal of Clinical Epidemiology. 1997 May 1
141 citations
A comparison of health-related quality of life in patients with epilepsy, diabetes and multiple sclerosis.
Bruce P. Hermann, Barbara G. Vickrey, Ron D. Hays, Joyce A. Cramer, Orrin Devinsky, Kimford J. Meador, Kenneth Perrine, Lawrence W. Myers, George W. Ellison> ;Epilepsy Research. 1996 Oct 1
19 citations
Comparative evaluations of neuroperformance and clinical outcome assessments in chronic progressive multiple sclerosis: I. Reliability, validity and sensitivity to dis...
Karl Syndulko, Dershin Ke, George W. Ellison, R.W. Baumhefner, Lawrence W. Myers, Wallace W Tourtellotte> ;Multiple Sclerosis. 1996 Oct 1
Polypharmacy in multiple sclerosis.
Myers LW, Phillips JT> ;Epilepsy Res. Suppl.. 1996-01-01
69 citations
Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled...
K P Johnson, B R Brooks, J A Cohen, C C Ford, J Goldstein, R P Lisak, L W Myers, H S Panitch, J W Rose, R B Schiffer> ;Neurology. 1995 Jul 1
714 citations
A Health-Related Quality of Life Measure for Multiple Sclerosis
Barbara G. Vickrey, Ron D. Hays, Rama Harooni, Lawrence W. Myers, George W. Ellison> ;Quality of Life Research. 1995 Jun 1
25 citations
Design strategies in multiple sclerosis clinical trials
George W. Ellison, Lawrence W. Myers, B. D. Leake, M. R. Mickey, D. Ke, Karl Syndulko, Wallace W. Tourtellotte> ;Annals of Neurology. 1994 Jan 1
5 citations
Preferential reductions in lymphocyte sub-populations induced by monthly pulses of chlorambucil: studies in patients with chronic progressive multiple sclerosis.
Francesco Chiappelli, Lawrence W. Myers, George W. Ellison, D. Liao, John L. Fahey> ;International Journal of Immunopharmacology. 1991 Jan 1
Join now to see all

Press Mentions

An Oxindole Efflux Inhibitor Potentiates Azoles and Impairs Virulence in the Fungal Pathogen Candida AurisDecember 22nd, 2020